Moore Family Trust Foundation
Moore Family Trust Foundation
Randal ‘Ran’ Moore
Randal "Ran" Moore serves as Chairman of Moore Capital Holdings and the Moore Family Trust Foundation. His work spans private investment, strategic business development, and philanthropy, with a longstanding commitment to medical research, education, the arts, and preservation.
Published by Lauren Fordes
Chief Communications Officer
Moore Capital Holdings
A Reflection on the Moore Family Trust Foundation
A Legacy Is Not Just Left ~ It Is Lived
Throughout the history of the Moore Family Trust Foundation, our philanthropic commitments have been guided by a fundamental belief: that thoughtful giving carries with it both an opportunity and a responsibility to create meaningful and lasting change.
Over the years, I have had the extraordinary privilege of witnessing this work firsthand—watching initiatives conceived with purpose grow into enduring commitments that have touched lives, strengthened communities, and created opportunities that extend far beyond what could have been envisioned at their inception.
The Foundation’s work has encompassed educational advancement, healthcare and medical research, humanitarian outreach, the arts, and community well-being. Although these endeavors are diverse in their purpose and reach, they share a common philosophy: meaningful philanthropy should not simply respond to the needs of the moment; it should seek to create the foundation for a better future.
Some initiatives have grown quietly over decades. Others have emerged in response to an immediate need or an opportunity to make a consequential difference. In every instance, our objective has remained consistent—to identify where our resources, relationships, and commitment can have a genuine and enduring impact.
I have also had the privilege of seeing what exists beyond the programs themselves: the students whose opportunities have been expanded through education; the patients and families given hope through advances in medicine and research; the communities strengthened through humanitarian initiatives; and the cultural institutions whose missions have been preserved and advanced for future generations.
These are the accomplishments that ultimately define the work of the Moore Family Trust Foundation.
They have been made possible through the exceptional generosity, vision, and steadfast leadership of our Chairman, Randal “Ran” G. Moore.
For more than three decades, Mr. Moore has guided the Foundation with an abiding commitment to responsible stewardship, compassionate service, and the conviction that those entrusted with great opportunity carry an equally significant responsibility to improve the lives of others.
Having worked alongside Ran for many years, I have witnessed a philosophy of philanthropy that places substance before recognition. Some of the Foundation’s most meaningful contributions have occurred quietly, without ceremony or public acknowledgment. That discretion has never diminished their significance. Indeed, it reflects a deeply held belief that the true measure of philanthropy lies not in recognition received, but in the difference ultimately made.
The passage of time provides a remarkable perspective. Programs that once began as ideas have become established traditions. Commitments made many years ago continue to provide opportunities today. Investments in people, institutions, research, and communities continue to produce benefits for individuals whom we may never have the privilege of knowing personally.
That continuity is perhaps among the Foundation’s greatest accomplishments.
As I reflect upon the work I have been privileged to witness, I do so with enormous gratitude—for the remarkable individuals and institutions with whom we have worked, for those who have entrusted us with their aspirations, and most importantly, for the countless lives that have been touched along the way.
The work of the Moore Family Trust Foundation has always been about more than philanthropy. It is about stewardship: preserving what has been entrusted to us, using it thoughtfully, and ensuring that its capacity to do good extends well beyond our own generation.
That responsibility has guided us throughout our history, and it will continue to guide the Foundation in the years ahead.
Phyllis Bennett
Chief of Staff
Director to the Chairman
Moore Family Trust Foundation
Tribute to a Titan, A Man of Honor and a Friend
William “Bill” H. Edwards Jr. was a titan of the healthcare industry. Over five decades of leadership, he brought uncommon judgment and vision to the work of improving how care was delivered. His contribution to the formation of the health and wellness sector at Moore Capital Holdings was immeasurable. He brought the same sense of purpose to his philanthropy, which was guided by a particular kindness toward those who were suffering.
After his diagnosis, Bill took up residence at the Four Seasons in Boston, where he stayed for several months while receiving care at Dana-Farber Cancer Institute. I was in Boston on business and telephoned to ask whether I might see him. He said how nice it would be to catch up. On the day of our visit, he was scheduled for a six-hour chemotherapy infusion and asked if I would mind coming to Dana-Farber.
I entered his room quietly and found Bill deep in conversation with Dr. Laurie Glimcher, who had served as Dana-Farber’s president and chief executive officer and was a dear friend to both Bill and Randal “Ran” Moore. I later learned that Laurie often came to sit with Bill during his treatments. That afternoon, much of their conversation centered on where cancer research was most urgently needed and how treatment might be improved for others. Then the conversation turned to Laurie’s grandchildren. Bill took obvious delight in her stories, and I remember how easily the room filled with warmth.
I kept my visit brief, but that afternoon stayed with me. Bill had only a few months left to live, and he was still thinking about what could be done for people who would face cancer after him. I was equally moved by the simple kindness of Laurie making time to sit beside a friend through a long treatment. Ran later told me that she also accompanied him to oncology appointments. Her friendship has remained a source of comfort to him since Bill’s death.
Bill in Honolulu Hawaii Date 1999
Bill returned home to Dallas, shortly after my visit. To his magnificent residence, surrounded by his books, and art. Where he was attended to by the best nurses and caregivers around the clock. Ran saw to every detail of his care and did all he could to make those final days peaceful. Bill died at home late in the evening on May 10, 2025, ten months and six days after his diagnosis.
When I think of what it means to face death with dignity, I think of Bill that afternoon. I remember his resolve, his concern for others, and the pleasure he still took in hearing a friend talk about her grandchildren.
On October 24, we honor what would have been Bill’s 72nd birthday. We remember the work he did, the kindness he showed, and the people who loved him. His was a life well lived and dearly missed.
Phyllis Bennett
Executive Director to the Chairman
Moore Capital Holdings Pbennett@moorecapitalholdings.com
Published by
Lauren Fordes
Chief Communication Officer
Moore Capital Holdings
lfordes@moorecapitalholdings.com
Contribution Content
Lisa Hubert
Senior Legal Counsel
Moore Capital Holdings
October 24, 2026
A Friend Indeed
Laurie H. Glimcher, MD, Dana-Farber President and CEO Emerita, Scientist, Scholar
Laurie H. Glimcher, MD, served as President and CEO of Dana-Farber Cancer Institute from 2016 to 2024 and is the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School. A distinguished immunologist, she is widely renowned for her work in one of the most promising areas of cancer research. She previously was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University.
Dr. Glimcher is a Member of the National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences, a Member of the American Philosophical Society, a Member of the National Academy of Medicine, and the former President of the American Association of Immunologists. She is a member of the Cancer Research Institute, Prix Galien, Parker Institute for Cancer Immunotherapy, Repare Therapeutics, Abpro Therapeutics Scientific Advisory Board, the Lasker Award Jury, the American Association for Cancer Research, the Association of American Cancer Institutes, and the American Society of Clinical Oncology, and served on U.S. Vice President Joe Biden’s Blue Ribbon panel in 2016. She previously served on the Board of Directors of the Bristol Myers Squibb Pharmaceutical Corporation, the Waters Corporation, and GSK plc. She currently serves as a consultant for the JPM Healthcare Advisory Committee and is on the Board of Directors of ReAlta Life Sciences.
A trailblazer in cancer research, Dr. Glimcher's research identified key transcriptional regulators of protective immunity and the origin of pathophysiologic immune responses underlying autoimmune, infectious, and malignant diseases. Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to the medical literature.
Aside from her research efforts, Dr. Glimcher has been a staunch proponent of improved access to care, health policy, and medical education, while simultaneously serving as a pioneering mentor and role model for cancer research trainees and for all women in science. Notably, she was the first female to be appointed Dean of Weill Cornell Medicine in New York, and first female President and Chief Executive Officer of Dana-Farber Cancer Institute.
Dr. Glimcher is the recipient of many awards and honors. In 2022, she was named to Modern Healthcare's 50 Most Influential Clinical Executives. In 2018, she received the American Association of Immunologists Lifetime Achievement Award; the Indiana University School of Medicine's Steven C. Beering Award for outstanding research contributions to advancement of biomedical or clinical science; and the L'Oréal-UNESCO Award for Women in Science. She has also received the 2017 George M. Kober Medal and the 2017 Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges (AAMC).
Dr. Glimcher is a magna cum laude graduate of Radcliffe College, and holds an MD degree cum laudefrom Harvard Medical School.
Sugar Rautbord
A Friendship of Decades. A Shared Commitment to Philanthropy.
The Moore Family Trust Foundation is pleased to announce the appointment of Sugar Rautbord to its Board, formally welcoming a woman whose friendship, counsel, and philanthropic perspective have been part of the Foundation’s history for decades.
A prominent American socialite, philanthropist, author, and patron of the arts, Sugar Rautbord was for many years one of the most recognizable figures within Chicago’s celebrated Gold Coast social and philanthropic circles. Now permanently residing in Palm Beach, Florida, she has remained closely engaged with the charitable, cultural, and philanthropic interests that have distinguished much of her life.
Quote From Our Chairman - Randal ‘Ran’ Moore
“We should all be fortunate enough to have that one special person who truly knows us—and loves us despite knowing us so well. For me, that person has been Sugar Rautbord.”
Ross Society Fellows
The MFA has formed the Ross Society Fellows to honor those who have contributed $1 million or more in funds to build and care for the Museum’s collection.
A Legacy Is Not Just Left ~ It Is Lived - One Generation to the Next.
Dinner and Cocktails for Ross Society Fellows - at the home of a patron; the next generation, at their Beacon Hill Residence.
Beacon Hill Preservation Society
Generational Traditions & Legacy
The Moore Family Trust Foundation
Halloween In Beacon Hill
The Moore Family Trust Foundation
Happy Halloween
The Moore Family Trust Foundation